New trends in radiotherapy for breast cancer

Current Opinion in Oncology

Volumn 18, Issue 6, 2006, Pages 555-562

  Limbergen, Erik Van ^a   Weltens, Caroline ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Accelerated partial breast irradiation; Breast cancer; Image guided radiation therapay; Intensity modulated radiation therapy; Radiotherapy

Indexed keywords

BRACHYTHERAPY; BREAST CANCER; CANCER CONTROL; CANCER PATIENT; CANCER RADIOTHERAPY; ELECTRON THERAPY; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HUMAN; INTRAOPERATIVE PERIOD; PRIORITY JOURNAL; PROTON THERAPY; RADIATION DOSE; REVIEW; SKIN TOXICITY; TREATMENT INDICATION; TREATMENT OUTCOME;

BRACHYTHERAPY; BREAST NEOPLASMS; FEMALE; HUMANS;

EID: 33748909342     PISSN: 10408746     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.cco.0000245327.42281.9f     Document Type: Review

References (89)

1. Polgár C, Major T, Fodor J, et al. HDR brachytherapy alone versus whole breast radiotherapy with or without tumor bed boost after breast conserving surgery: seven year results of a comparative study. Int J Radiat Oncol Biol Phys 2004; 60:1173-1181.
2. King TA, Bolton JS, Kuske RR, et al. Long-term results of wide-field brachytherapy as the sole method of radiation therapy after segmental mastectomy for Tis,1,2 breast cancer. Am J Surg 2000; 180:299-304.
3. Samuel LM, Dewar JA, Preece PE, et al. A pilot study of radical radiotherapy using a peroperative implant following wide local excision for carcinoma of the breast. Breast 1999; 8:95-97.
4. Vicini FA, Kestin L, Chen P, et al. Limited-field radiation therapy in the management of early-stage breast cancer. J Natl Cancer Inst 2003; 95:1205-1210.
5. Lawenda BD, Taghian AG, Kachnic LA, et al. Dose-volume analysis of radiotherapy for T1N0 invasive breast cancer treated by local excision and partial breast irradiation by low-dose-rate interstitial implant. Int J Radiat Oncol Biol Phys 2003; 56:671-680.
6. Krishnan L, Jewell WR, Tawfik OW, et al. Breast conservation therapy with tumour bed irradiation alone in a selected group of patients with stage I breast cancer. Breast 2001; 7:91-96.
7. Arthur DW, Koo D, Zwicker RD, et al. Partial breast brachytherapy after lumpectomy: low-dose-rate and high-dose-rate experience. Int J Radiat Oncol Biol Phys 2003; 56:681-689.
8. Keisch M, Vicini F, Kuske R, et al. Initial clinical experience with the Mammo-Site breast brachytherapy applicator in women with early stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys 2003; 55:289-293.
9. Vicini F, Remouchamps V, Wallace RN, et al. Ongoing clinical experience utilizing 3D conformal external beam radiotherapy to deliver partial-breast irradiation in patients with early stage breast cancer treated with breast-conserving surgery. Int J Radiat Oncol Biol Phys 2003; 57:1247-1253.
10. Veronesi U, Gatti G, Luini A, et al. Intra-operative radiation therapy for breast cancer: technical notes. Breast J 2003; 9:106-112.
11. Vaidya, Baum M, Tobias JS, et al. The novel technique of delivering targeted intra-operative radiotherapy (Targit) for early breast cancer. Eur J Surg Oncol 2002; 8:447-454.
12. Keisch M, Arthur DW. Current perspective on the MammoSite Radiation Therapy System: a balloon breast brachytherapy applicator. Brachytherapy 2005; 4:177-180. Recent overview of the early experience with the MSB.
13. DiFronzo LA, Tsai PI, Hwang JM, et al. Breast conserving surgery and accelerated partial breast irradiation using the MammoSite system: initial clinical experience. Arch Surg 2005; 140:787-794.
14. Zannis V, Beitsch P, Vicini F, et al. Descriptions and outcomes of insertion techniques of a breast brachytherapy balloon catheter in 1403 patients enrolled in the American Society of Breast Surgeons MammoSite breast brachytherapy registry trial. Am J Surg 2005; 190:530-538.
15. Haffty BG. Accelerated partial breast irradiation: where do we go from here? Breast J 2005; 11:303-305.
16. Hanley KY, Beckman A, Hayne M. Advances in treating early breast cancer. JAAPA 2005; 18:54, 56, 59-62.
17. Kaufman SA, DiPetrillo TA, Wazer DE. Accelerated partial breast irradiation: current modalities and investigations. Med Health R I 2006; 89:70-73.
18. Keisch ME. Accelerated partial breast irradiation: a valid choice. Breast Cancer Res 2005; 7:165.
19. Keisch ME. Accelerated partial breast irradiation: the case for current use. Breast Cancer Res 2005; 7:106-109.
20. Keisch M. MammoSite. Expert Rev Med Devices 2005; 2:387-394.
21. Kini V. Balloon breast brachytherapy: review of current data. Brachytherapy 2005; 4:181-182.
22. McCormick B. Partial-breast radiation for early staged breast cancers: hypothesis, existing data, and a planned phase III trial. J Natl Compr Canc Netw 2005; 3:301-307.
23. Patel RR, Das RK. Image-guided breast brachytherapy: an alternative to whole-breast radiotherapy. Lancet Oncol 2006; 7:407-415. Excellent overview of image guided partial breast brachytherapy techniques with quality control, target delineation and dose-volume optimization.
24. Taghian AG, Recht A. Update on accelerated partial-breast irradiation. Curr Oncol Rep 2006; 8:35-41.
25. White J. MammoSite and accelerated partial breast irradiation: rethinking one-size-fits-all breast irradiation after lumpectomy. Brachytherapy 2005; 4:183-185.
26. Jansen N, Nickers P, Deneufbourg JM. Partial breast irradiation: the role of brachytherapy: a new treatment option for early breast cancer. Rev Med Liege 2006; 61:97-103.
27. Marsiglia H, Chajon E. Evolution in brachytherapy. Clin Transl Oncol 2006; 8:63-65.
28. Peiffert D. What is new in brachytherapy? Bull Cancer 2006; 93:125-132.
29. Sauer R, Wenz F, Strnad V, et al. Partial breast irradiation after breast-conserving surgery for breast cancer. Strahlenther Onkol 2005; 181:417-423.
30. Bernard S, Reniers B, Scalliet P, Vynckier S. Optimization of a breast implant in Brachytherapy PDR: validation with Monte Carlo simulation and measurements with TLDs and GafChromic films. Radiother Oncol 2005; 76:326-333.
31. Chen PY, Vicini FA, Benitez P, et al. Long-term cosmetic results and toxicity after accelerated partial-breast irradiation: a method of radiation delivery by interstitial brachytherapy for the treatment of early-stage breast carcinoma. Cancer 2006; 106:991-999. Long-term data on side effects from multicatheter brachytherapy.
32. Das RK, Bradley KA, Nelson IA, et al. Quality assurance of treatment plans for interstitial and intracavitary high-dose-rate brachytherapy. Brachytherapy 2006; 5:56-60.
33. Hui SK, Das RK. Optimization of conformal avoidance: a comparative study of prone vs supine interstitial high-dose-rate breast brachytherapy. Brachytherapy 2005; 4:137-140.
34. Kuske RR, Winter K, Arthur DW, et al. Phase II trial of brachytherapy alone after lumpectomy for select breast cancer: toxicity analysis of RTOG 95-17. Int J Radiat Oncol Biol Phys 2006; 65:45-51. Medium term toxicity data for multicatheter brachytherapy.
35. Major T, Niehoff P, Kovacs G, et al. Dosimetric comparisons between high dose rate interstitial and MammoSite balloon brachytherapy for breast cancer. Radiother Oncol 2006; 79:321-328. Excellent dosimetric study showing similar target covering and better skin sparing with multicatheter brachytherapy compared with intracavitary balloon brachytherapy.
36. Perera F, Chisela F, Stitt L, et al. TLD skin dose measurements and acute and late effects after lumpectomy and high-dose-rate brachytherapy only for early breast cancer. Int J Radiat Oncol Biol Phys 2005; 62:1283-1290. Clinical study relating skin doses with early and late side effects.
37. Slampa P, Soumarova R, Ruzickova J, et al. Pilot study of sole conformal peroperative interstitial brachyradiotherapy of early stage breast carcinoma using high-dose rate afterloading. Neoplasma 2005; 52:292-296.
38. Stevens MJ, Cooper SG, Cross P, Wang Y. Accelerated partial breast irradiation using interstitial high dose rate iridium brachytherapy: early Australian experience and review of the literature. Australas Radiol 2006; 50:143-151.
39. Suh WW, Pierce LJ, Vicini FA, Hayman JA. A cost comparison analysis of partial versus whole-breast irradiation after breast-conserving surgery for early-stage breast cancer. Int J Radiat Oncol Biol Phys 2005; 62:790-796.
40. Cheng CW, Mitra R, Li XA, Das IJ. Dose perturbations due to contrast medium and air in mammosite treatment: an experimental and Monte Carlo study. Med Phys 2005; 32:2279-2287.
41. Dickler A, Kirk MC, Choo J, et al. Cosmetic outcome and incidence of infection with the MammoSite breast brachytherapy applicator. Breast J 2005; 11:306-310.
42. Dragun AE, Aguero EG, Harmon JF, et al. Chest wall dose in MammoSite breast brachytherapy: radiobiologic estimations of late complication risk based on dose-volume considerations. Brachytherapy 2005; 4:259-263.
43. Kaufman SA, Dipetrillo TA, Ruthazer R, Wazer DE. MammoSite excision volume as a predictor for residual disease. Cancer 2005; 104:906-912.
44. Kirk M, Hsi WC, Dickler A, et al. Surface optimization technique for Mammo-Site breast brachytherapy applicator. Int J Radiat Oncol Biol Phys 2005; 62:366-372.
45. Vicini FA, Beitsch PD, Quiet CA, et al. First analysis of patient demographics, technical reproducibility, cosmesis, and early toxicity: results of the American Society of Breast Surgeons MammoSite breast brachytherapy trial. Cancer 2005; 104:1138-1148. Early results of cosmesis and side effects of intracavitary balloon brachytherapy in the American Society of Breast Surgeons MammoSite breast brachytherapy trial.
46. Nairz O, Deutschmann H, Kopp M, et al. A dosimetric comparison of IORT techniques in limited-stage breast cancer. Strahlenther Onkol 2006; 182:342-348.
47. Veronesi U, Orecchia R, Luini A, et al. Full-dose intraoperative radiotherapy with electrons during breast-conserving surgery: experience with 590 cases. Ann Surg 2005; 242:101-106. First data on the IORT-APBI technique showing excellent local control and toxicity results at 20 (4-57) months of follow-up.
48. Pignol JP, Keller B, Rakovitch E, et al. First report of a permanent breast 103Pd seed implant as adjuvant radiation treatment for early-stage breast cancer. Int J Radiat Oncol Biol Phys 2006; 64:176-181. First report on the feasibility of a permanent breast palladium seed in breast cancer.
49. Taghian AG, Kozak KR, Katz A, et al. Accelerated partial breast irradiation using proton beams: initial dosimetric experience. Int J Radiat Oncol Biol Phys (in press). First dosimetrical data on proton beam APBI showing excellent target covering and nontarget tissue sparing.
50. Wazer DE, Berle L, Graham R, et al. Preliminary results of a phase I/II study of HDR brachytherapy alone for T1/T2 breast cancer. Int J Radiat Oncol Biol Phys 2002; 53:889-897.
51. Keller B, Sankreacha R, Rakovitch E, et al. A permanent breast seed implant as partial breast radiation therapy for early-stage patients: a comparison of palladium-103 and iodine-125 isotopes based on radiation safety considerations. Int J Radiat Oncol Biol Phys 2005; 62:358-365.
52. Godinez J, Gombos EC. A permanent breast seed implant as partial-breast radiation therapy for early-stage patients: in regards to Keller et al. Int J Radiat Oncol Biol Phys 2006; 64:1611.
53. Reitsamer R, Peintinger F, Sedlmayer F, et al. Accelerated partial breast irradiation after conservative surgery for breast cancer. Ann Surg 2005; 242:147-148.
54. Van Limbergen E, Briot E, Drijkoningen M. The skin-source measuring bridge: a method to avoid radiation teleangiectasia in the skin after interstitial implants for breast cancer. Int J Radiat Oncol Biol Phys 1990; 18:1239-1244.
55. Georg P, Georg D, Van Limbergen E. The use of the source-skin distance measuring bridge indeed reduces skin teleangiectasia after interstitial boost in breast conserving therapy. Radiother Oncol 2005; 74:323-330. First clinical paper relating late skin damage to skin-source distances in breast brachytherapy.
56. Turesson I, Notter G. The influence of fraction size in radiotherapy on the late normal tissue reaction (I+II). Int J Radiat Oncol Biol Phys 1984; 10:593-606.
57. Keisch M, Vicini F, Scroggins T, et al. Thirty months results with the Mammosite breast brachytherapy applicator: cosmesis, toxicity and local control in partial breast irradiation. Int J Radiat Oncol Biol Phys 2004; 60:272.
58. Jeruss JS, Vicini FA, Beitch PD, et al. Initial outcomes for patients treated on the American Society of Breast Surgeons MammoSite clinical Trial for Ductal Carcinoma in situ of the breast. Ann Surg Oncol 2006; 13:967-976.
59. Senkus-Konefka E, Jassem J. Complications of breast-cancer radiotherapy. Clin Oncol (R Coll Radiol) 2006; 18:229-235.
60. Marks LB, Yu X, Prosnitz RG, et al. The incidence and functional consequences of RT-associated cardiac perfusion defects. Int J Radiat Oncol Biol Phys 2005; 63:214-223. Radiotherapy causes volume dependent perfusion defects of which the long-term consequences still have to be studied.
61. Taghian AG, Assaad SI, Niemierko A, et al. Is a reduction in radiation lung volume and dose necessary with paclitaxel chemotherapy for node-positive breast cancer? Int J Radiat Oncol Biol Phys 2005; 62:386-391. This study shows that in breast cancer patients, administration of paclitaxel, whether sequentially or concurrently with radiotherapy, may be associated with an increased risk of radiation pneumonitis.
62. Cho BC, Schwarz M, Mijnheer BJ, Bartelink H. Simplified intensity-modulated radiotherapy using predefined segments to reduce cardiac complications in left-sided breast cancer. Radiother Oncol 2004; 70:231-241.
63. Donovan EM, Johnson U, Shentall G, et al. Evaluation of compensation in breast radiotherapy: a planning study using multiple static fields. Int J Radiat Oncol Biol Phys 2000; 46:671-679.
64. Donovan E, Bleakley N, Evan P, et al. Dose-position and dose-volume histogram analysis of standard wedged and intensity modulated treatments in breast radiotherapy. Br J Radiol 2002; 75:967-973.
65. Evans PM, Donovan EM, Partridge M, et al. The delivery of intensity modulated radiotherapy to the breast using multiple static fields. Radiother Oncol 2000; 5:79-89.
66. Fogliata A, Nicolini G, Alber M, et al. IMRT for breast: a planning study. Radiother Oncol 2005; 76:300-310. In this paper the performance of 10 different treatment planning systems is evaluated for IMRT of the breast.
67. Mayo CS, Urie MM, Fitzgerald TJ. Hybrid IMRT plans: concurrently treating conventional and IMRT beams for improved breast irradiation and reduced planning time. Int J Radiat Oncol Biol Phys 2005; 61:922-932. In this dosimetrical study a class solution for breast IMRT is developed.
68. Mihai A, Rakovitch E, Sixel K, et al. Inverse vs. forward breast IMRT planning. Med Dosim 2005; 30:149-154.
69. van Asselen B, Schwarz M, van Vliet-Vroegindeweij C, et al. Intensity-modulated radiotherapy of breast cancer using direct aperture optimization. Radiother Oncol 2006; 79:162-169.
70. Vicini F, Sharpe M, Kestin L, et al. Optimizing breast cancer treatment efficacy with intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 2002; 54:1336-1344.
71. Hall EJ. Intensity-modulated radiation therapy, protons, and the risk of second cancers. Int J Radiat Oncol Biol Phys 2006; 65:1-7. In this important paper the authors warn of a potentially doubled incidence of solid cancer in long-term survivors after treatment with IMRT.
72. Smith RE, Bryant J, DeCillis A, Anderson S. Acute myeloid leukemia and myelodysplastic syndrome after doxorubicin-cyclophosphamide adjuvant therapy for operable breast cancer: the National Surgical Adjuvant Breast and Bowel Project Experience. J Clin Oncol 2003; 21:1195-1204.
73. Clarke M, Collins R, Darby S, et al. Effects of radiotherapy and of differences inthe extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005; 366:2087-2106.
74. Bhatnagar AK, Brandner E, Sonnik D, et al. Intensity modulated radiation therapy (IMRT) reduces the dose to the contralateral breast when compared to conventional tangential fields for primary breast irradiation. Breast Cancer Res Treat 2005; 95:35-39. This interesting paper demonstrates that a two-tangential IMRT technique reduces the dose to the contralateral breast in comparison to wedged fields and therefore potentially lowers the risk of radiation induced contralateral breast cancer.
75. Woo TC, Pignol JP, Rakovitch E, et al. Body radiation exposure in breast cancer radiotherapy: impact of breast IMRT and virtual wedge compensation techniques. Int J Radiat Oncol Biol Phys 2006; 65:52-58. This paper shows a reduction of body exposure with IMRT in comparison with the conventional technique with physical wedges.
76. Struikmans H, Warlam-Rodenhuis C, Stam T, et al. Interobserver variability of clinical target volume delineation of glandular breast tissue and of boost volume in tangential breast irradiation. Radiother Oncol 2005; 76:293-299. This important paper addresses the problem of interobserver variations in CTV delineation for breast cancer using a lead wire marking the palpable boundaries of the breast. Relatively low variability is reported.
77. Hurkmans CW, Borger JH, Pieters BR, et al. Variability in target volume delineation on CT scans of the breast. Int J Radiat Oncol Biol Phys 2001; 50:1366-1372.
78. Dijkema IM, Hofman P, Raaijmakers CP, et al. Loco-regional conformal radiotherapy of the breast: delineation of the regional lymph node clinical target volumes in treatment position. Radiother Oncol 2004; 71:287-295.
79. Remouchamps V, Vicini F, Sharpe M, et al. Significant reductions in heart and lung doses using deep inspiration breath holt with active breathing control and intensity-modulated radiation therapy for patients treated with locoregional breast irradiation. Int J Radiat Oncol Biol Phys 2003; 55:392-406.
80. Frazier R, Vicini F, Sharpe M, et al. Impact of breathing motion on whole breast radiotherapy: a dosimetric analysis using active breathing control. Int J Radiat Oncol Biol Phys 2004; 15:1041-1047.
81. George R, Keall P, Kini V, et al. Quantifying the effect of intrafraction motion during breast IMRT planning and dose delivery. Med Phys 2003; 30:552-562.
82. Thilmann C, Haring P, Thilmann L, et al. The influence of breathing motion on intensity modulated radiotherapy in the step-and-shoot technique: phantom measurements for irradiation of superficial target volumes. Phys Med Biol 2006; 51:117-126.
83. Korreman SS, Pedersen AN, Aarup LR, et al. Reduction of cardiac and pulmonary complication probabilities after breathing adapted radiotherapy for breast cancer. Int J Radiat Oncol Biol Phys 2006; 65:1375-1380. This paper reports on the potential of breath hold techniques to reduce the risk of cardiac and pulmonary toxicity in breast cancer radiotherapy.
84. Sidhu S, Sidhu NP, Lapointe C, Gryschuk G. The effects of intrafraction motion on dose homogeneity in a breast phantom with physical wedges, enhanced dynamic wedges, and ssIMRT. Int J Radiat Oncol Biol Phys 2006; 4 June [Epub ahead of print]. This phantom study shows that gating improves dose homogeneity and decreases doses to the lung.
85. Krauss DJ, Kestin LL, Raff G, et al. MRI-based volumetric assessment of cardiac anatomy and dose reduction via active breathing control during irradiation for left-sided breast cancer. Int J Radiat Oncol Biol Phys 2005; 61:1243-1250.
86. Krueger E, Fraass B, McShan D, et al. Potential gains for irradiation of chest wall and regional nodes with intensity modulated radiotherapy. Int J Radiat Oncol Biol Phys 2003; 56:1023-1037.
87. Lomax A, Cella L, Weber D, et al. Potential role of intensity-modulated photons and protons in the treatment of the breast and regional nodes. Int J Radiat Oncol Biol Phys 2003; 55:785-792.
88. Chui CS, Hong L, McCormick B. Intensity-modulated radiotherapy technique for three-field breast treatment. Int J Radiat Oncol Biol Phys 2005; 62:1217-1223.
89. Freedman GM, Anderson PR, Li J, et al. Intensity modulated radiation therapy (IMRT) decreases acute skin toxicity for women receiving radiation for breast cancer. Am J Clin Oncol 2006; 29:66-70. This paper is one of the few papers reporting on clinical outcome of IMRT and shows a decreased acute skin toxicity in comparison to a matched cohort of women treated with conventional radiation therapy.